1. Breaking Tolerance to Invoke an Immune Response to Cancer (Melanoma)Introduction:This paper is dedicated to all the Melanoma Patients that aren’t here today but wereinstrumental…

1. QClamp® XNA-PCR A highly sensitive, rapid, cost effective technology for low frequency & cell free circulating mutant DNA detection Mike Powell, PhD CSO, DiaCarta,…

Slide 1 Melanoma Network of Canada Annette Cyr, Chair, MNC Slide 2 Our Organization To provide melanoma patients and their caregivers with current and accurate information…

Slide 1 Dose finding designs driven by immunotherapy outcomes with Application to a metastatic melanoma phase I trial Elizabeth Garrett-Mayer, PhD Cody Chiuzan, MS Hollings…

Slide 1 GENTA (GNTA) www.genta.com Recent stock price: 12.44 (2/17/04 close) 52-wk range: 5.50 – 17.65 Market cap: 923 Mil Diluted EPS: - 0.66 Revenue: 5.2 Mil ttm Expenses:…

Slide 1 Harnessing the Power of the Host Immune System to Fight Cancer Robert Kastelein Immuno-Oncology Discovery Texas FreshAIR Conference 2014 Houston October 23-24 Slide…

Slide 1 MELANOMA Olivia Wilson Slide 2 What is Melanoma?  Melanoma is the most serious type of skin cancer  It can be found in the digestive tract and lymph nodes because…

Slide 1 Introducing Apceden™ Slide 2 Topics IMMUNITY AND CANCER DENDRITIC CELL BIOLOGY – Development of Dendritic Cells – Why Dendritic Cells – Mechanism of Action…

Slide 1 Slide 2 Stress The source of disease Slide 3 Stress is at the root of most disease High cholesterol Heart disease High blood pressure Colitis and irritable bowel…

Part II – Melanoma: Novel Pathways and Agents Tuesday, June 21, 2011 7:30 PM – 8:30 PM ET RTP TV: An 8-Part Live CME Webcast Series Keith T Flaherty, MD Associate Professor…